BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17626709)

  • 1. Predicting the risk of a false-positive test for women following a mammography screening programme.
    Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
    J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation behaviour following a false positive test in the Copenhagen mammography screening programme.
    Andersen SB; Vejborg I; von Euler-Chelpin M
    Acta Oncol; 2008; 47(4):550-5. PubMed ID: 18465321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.
    Castells X; Molins E; Macià F
    J Epidemiol Community Health; 2006 Apr; 60(4):316-21. PubMed ID: 16537348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
    Hofvind S; Thoresen S; Tretli S
    Cancer; 2004 Oct; 101(7):1501-7. PubMed ID: 15378474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
    Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
    Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
    Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
    Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme.
    Molins E; Comas M; Román R; Rodríguez-Blanco T; Sala M; Macià F; Murta-Nascimento C; Castells X
    Public Health; 2009 Sep; 123(9):635-7. PubMed ID: 19733372
    [No Abstract]   [Full Text] [Related]  

  • 9. Performance of systematic and non-systematic ('opportunistic') screening mammography: a comparative study from Denmark.
    Bihrmann K; Jensen A; Olsen AH; Njor S; Schwartz W; Vejborg I; Lynge E
    J Med Screen; 2008; 15(1):23-6. PubMed ID: 18416951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
    J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
    Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
    J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reviewing interval cancers: time well spent?
    Gower-Thomas K; Fielder HM; Branston L; Greening S; Beer H; Rogers C
    Clin Radiol; 2002 May; 57(5):384-8. PubMed ID: 12014936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results.
    Weedon-Fekjaer H; Vatten LJ; Aalen OO; Lindqvist B; Tretli S
    J Med Screen; 2005; 12(4):172-8. PubMed ID: 16417693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the cumulative risk of a false-positive under a regimen involving various types of cancer screening tests.
    Baker SG; Kramer BS
    J Med Screen; 2008; 15(1):18-22. PubMed ID: 18416950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program.
    Olsen AH; Agbaje OF; Myles JP; Lynge E; Duffy SW
    Breast J; 2006; 12(4):338-42. PubMed ID: 16848843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme.
    Brain K; Henderson BJ; Tyndel S; Bankhead C; Watson E; Clements A; Austoker J;
    Psychooncology; 2008 Dec; 17(12):1180-8. PubMed ID: 18506670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early outcome of mammography screening in Copenhagen 1991-99.
    Vejborg I; Olsen AH; Jensen MB; Rank F; Tange UB; Lynge E
    J Med Screen; 2002; 9(3):115-9. PubMed ID: 12370322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities.
    Boncz I; Sebestyén A; Pintér I; Battyány I; Ember I
    J Med Screen; 2008; 15(1):14-7. PubMed ID: 18416949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of interval breast cancers after 650,000 negative mammographies in 13 Italian health districts.
    Bucchi L; Ravaioli A; Foca F; Colamartini A; Falcini F; Naldoni C;
    J Med Screen; 2008; 15(1):30-5. PubMed ID: 18416953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.